Indonesia · Delayed Price · Currency is IDR PT Medikaloka Hermina Tbk Statistics
Total Valuation
IDX:HEAL has a market cap or net worth of IDR 11.59 trillion. The enterprise value is 16.24 trillion.
| Market Cap | 11.59T |
| Enterprise Value | 16.24T |
Important Dates
The next estimated earnings date is Thursday, October 22, 2026.
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | May 5, 2026 |
Share Statistics
IDX:HEAL has 15.25 billion shares outstanding. The number of shares has increased by 3.06% in one year.
| Current Share Class | 15.25B |
| Shares Outstanding | 15.25B |
| Shares Change (YoY) | +3.06% |
| Shares Change (QoQ) | -0.58% |
| Owned by Insiders (%) | 26.89% |
| Owned by Institutions (%) | 4.57% |
| Float | 8.04B |
Valuation Ratios
The trailing PE ratio is 29.30 and the forward PE ratio is 21.74. IDX:HEAL's PEG ratio is 1.53.
| PE Ratio | 29.30 |
| Forward PE | 21.74 |
| PS Ratio | 1.58 |
| PB Ratio | 1.63 |
| P/TBV Ratio | 2.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 9.59 |
| PEG Ratio | 1.53 |
Enterprise Valuation
| EV / Earnings | 40.81 |
| EV / Sales | 2.21 |
| EV / EBITDA | 9.11 |
| EV / EBIT | 17.35 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.27 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | 2.04 |
| Debt / FCF | -10.58 |
| Interest Coverage | 4.06 |
Financial Efficiency
Return on equity (ROE) is 7.28% and return on invested capital (ROIC) is 6.64%.
| Return on Equity (ROE) | 7.28% |
| Return on Assets (ROA) | 4.89% |
| Return on Invested Capital (ROIC) | 6.64% |
| Return on Capital Employed (ROCE) | 9.14% |
| Weighted Average Cost of Capital (WACC) | 3.61% |
| Revenue Per Employee | 382.34M |
| Profits Per Employee | 20.69M |
| Employee Count | 19,235 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 39.21 |
Taxes
In the past 12 months, IDX:HEAL has paid 206.52 billion in taxes.
| Income Tax | 206.52B |
| Effective Tax Rate | 28.68% |
Stock Price Statistics
The stock price has decreased by -53.33% in the last 52 weeks. The beta is -0.17, so IDX:HEAL's price volatility has been lower than the market average.
| Beta (5Y) | -0.17 |
| 52-Week Price Change | -53.33% |
| 50-Day Moving Average | 839.60 |
| 200-Day Moving Average | 1,203.15 |
| Relative Strength Index (RSI) | 34.38 |
| Average Volume (20 Days) | 10,317,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:HEAL had revenue of IDR 7.35 trillion and earned 397.88 billion in profits. Earnings per share was 25.94.
| Revenue | 7.35T |
| Gross Profit | 2.31T |
| Operating Income | 935.66B |
| Pretax Income | 720.20B |
| Net Income | 397.88B |
| EBITDA | 1.77T |
| EBIT | 935.66B |
| Earnings Per Share (EPS) | 25.94 |
Balance Sheet
The company has 571.79 billion in cash and 3.64 trillion in debt, with a net cash position of -3,066.34 billion or -201.13 per share.
| Cash & Cash Equivalents | 571.79B |
| Total Debt | 3.64T |
| Net Cash | -3,066.34B |
| Net Cash Per Share | -201.13 |
| Equity (Book Value) | 7.10T |
| Book Value Per Share | 361.72 |
| Working Capital | 474.40B |
Cash Flow
In the last 12 months, operating cash flow was 1.21 trillion and capital expenditures -1,552.09 billion, giving a free cash flow of -343.75 billion.
| Operating Cash Flow | 1.21T |
| Capital Expenditures | -1,552.09B |
| Depreciation & Amortization | 833.66B |
| Net Borrowing | 22.02B |
| Free Cash Flow | -343.75B |
| FCF Per Share | -22.55 |
Margins
Gross margin is 31.41%, with operating and profit margins of 12.72% and 5.41%.
| Gross Margin | 31.41% |
| Operating Margin | 12.72% |
| Pretax Margin | 9.79% |
| Profit Margin | 5.41% |
| EBITDA Margin | 24.06% |
| EBIT Margin | 12.72% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 10.50, which amounts to a dividend yield of 1.36%.
| Dividend Per Share | 10.50 |
| Dividend Yield | 1.36% |
| Dividend Growth (YoY) | 28.57% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 51.73% |
| Buyback Yield | -3.06% |
| Shareholder Yield | -1.72% |
| Earnings Yield | 3.43% |
| FCF Yield | -2.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for IDX:HEAL is 1,436.07, which is 88.96% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,436.07 |
| Price Target Difference | 88.96% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (3Y) | 9.38% |
| EPS Growth Forecast (3Y) | 13.62% |
Stock Splits
The last stock split was on July 30, 2021. It was a forward split with a ratio of 5.
| Last Split Date | Jul 30, 2021 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
IDX:HEAL has an Altman Z-Score of 3.87 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.87 |
| Piotroski F-Score | 5 |